Listen Live

Community Corner Interview: COVID-19 Impact on Sprint Pavilion

Community Corner Interview: COVID-19 Impact on Sprint Pavilion

Photo: clipart.com, 106.1 The Corner


Melissa chats with Kirby Hutto, the General Manager of the Sprint Pavilion about how COVID-19 restrictions will impact the venue and the future of the announced shows. http://www.sprintpavilion.com/

Are you interested in doing a community corner interview? Reach out to Kendall at kendall@1061thecorner.com

 

Latest News

5 hours ago in Business, Education, Entertainment, Lifestyle, Local, Shop Simply

Deal Days is your chance to get one of those most popular ad blockers for life, only $14.97

AdGuard Offers Lifetime Ad Blocking and Parental Controls for $14.97

Charlottesville readers can get AdGuard’s lifetime Family Plan for up to nine devices for $14.97 through October 11. The offer is available to new users only.

6 hours ago in Albemarle County, Charlottesville City, Local

City Council, County Supervisors look to increase collaboration

City Council and Board of Supervisors joint meeting

At the joint meeting between the two boards, members from both expressed a further desire to communicate on issues like regional transit and revenue-sharing.

6 hours ago in Entertainment

Eva Marie Saint, star of ‘North by Northwest’ and ‘On the Waterfront,’ dies at 102

Eva Marie Saint, the pale, willowy actor who won an Academy Award for her first movie, "On the Waterfront," and starred opposite Cary Grant in the Alfred Hitchcock thriller "North by Northwest," has died. She was 102.

7 hours ago in National, Trending

Tropical Storm Isaias forms, is forecast to become a hurricane and hit US Gulf Coast this week

Tropical Storm Isaias formed early Wednesday in the warm waters off eastern Mexico and forecasters said it was expected to strengthen into the first hurricane of the Atlantic season before hitting the U.S. Gulf Coast later in the week.

10 hours ago in Albemarle County, Charlottesville City, Local, UVA

FDA approves breakthrough Parkinson’s drug developed by UVA Health researchers

Targets the specific cells that produce dopamine and need only be taken once a day